
CYTK
Cytokinetics, IncorporatedNASDAQHealthcare$66.73+0.18%ClosedMarket Cap: $8.22B
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
0
Sales
1
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Apr 01 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $66.63 | 422,830 |
| Tue Mar 31 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 3,639 | $65.00 | 66,004 |
| Wed Mar 18 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 2,916 | $62.15 | 71,573 |
| Wed Mar 18 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 7,636 | $62.15 | 158,299 |
| Wed Mar 18 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 4,397 | $62.15 | 153,902 |
| Wed Mar 18 | Blum Robert I | director, officer: President & CEO | Sell | 12,673 | $62.15 | 454,258 |
| Wed Mar 18 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 4,935 | $62.15 | 87,127 |
| Wed Mar 18 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 1,930 | $62.07 | 78,185 |
| Wed Mar 18 | Blum Robert I | director, officer: President & CEO | Sell | 23,928 | $62.15 | 430,330 |
| Wed Mar 18 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 5,626 | $62.15 | 74,489 |
| Tue Mar 17 | Blum Robert I | director, officer: President & CEO | Sell | 111,864 | $60.06 | 111,864 |
| Tue Mar 17 | Blum Robert I | director, officer: President & CEO | Sell | 75,258 | $0.00 | 466,931 |